Deutsche Bank
ALDX icon

Deutsche Bank’s Aldeyra Therapeutics ALDX Stock Holding History

Deutsche Bank’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-200
Closed -$1K – 5265
2019
Q1 		$1K Buy
+200
New +$1.7K ﹤0.01% 5100

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank's ALDX Position: Q1 2026 in Review

Deutsche Bank reduced its Aldeyra Therapeutics (ALDX) stake by 84% in Q1 2026, selling an estimated $1.17M and leaving 50,271 shares worth $85K. The position accounts for ﹤0.01% of the portfolio, ranked #3331.

Deutsche Bank first reported a position in ALDX in Q2 2014 and has held it in 38 quarters since. The position peaked at $3.56M in Q1 2021. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

  • Deutsche Bank held 50,271 shares of Aldeyra Therapeutics worth $85K as of Q1 2026.
  • Deutsche Bank sold 267,064 Aldeyra Therapeutics shares in Q1 2026, an estimated $1.17M.
  • Aldeyra Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3331 holding.
  • Deutsche Bank first reported a position in Aldeyra Therapeutics in Q2 2014 and has held it in 38 quarters since.
  • Deutsche Bank's Aldeyra Therapeutics position peaked at $3.56M in Q1 2021.
  • 126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.